May

Articles

AMR and the environment: A global and one health security issue

MBI researchers discuss the role of agriculture driving antifungal AMR in Vietnam, in this recent publication from Geneva-based AMR Think-Do-Tank.

9 ways we can make it easier for Australians to get the COVID-19 vaccine

There are tangible things we can do now to help people understand the benefits and possible risks of COVID-19 vaccination, and get the vaccine quickly as soon as they’re eligible.

Grant success for MBI researcher in the PhD partnership program

Associate Professor Julianne Djordevic’s project entitled Developing inhibitors of fungal inositol polyphosphate kinases as a novel class of antifungal drug , has been funded ,and will allow her PhD student Desmarini Desmarini to work alongside industry partner, Biodiem, a subsidiary of Opal Biosciences Australia, who will provide mentoring and engagement with external industry.